tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BRRGF Stock Latest News

Oncoinvent ASA Appoints Dr. Ramzi Amri as New CFO
Company AnnouncementsOncoinvent ASA Appoints Dr. Ramzi Amri as New CFO
2d ago
BerGenBio ASA Completes Merger with Oncoinvent ASA
PremiumCompany Announcements
BerGenBio ASA Completes Merger with Oncoinvent ASA
3d ago
BerGenBio and Oncoinvent Complete Strategic Merger
PremiumCompany Announcements
BerGenBio and Oncoinvent Complete Strategic Merger
4d ago
BerGenBio ASA Announces Merger and Rights Issue Approval
PremiumCompany Announcements
BerGenBio ASA Announces Merger and Rights Issue Approval
5d ago
BerGenBio and Oncoinvent Announce Merger Completion Date
PremiumCompany Announcements
BerGenBio and Oncoinvent Announce Merger Completion Date
9d ago
BerGenBio Announces Delays in Merger and Rights Issue Timeline
PremiumCompany AnnouncementsBerGenBio Announces Delays in Merger and Rights Issue Timeline
2M ago
BerGenBio ASA Merges with Oncoinvent to Boost Cancer Innovation
Premium
Company Announcements
BerGenBio ASA Merges with Oncoinvent to Boost Cancer Innovation
2M ago
BerGenBio ASA Announces Strategic Merger with Oncoinvent ASA
Premium
Company Announcements
BerGenBio ASA Announces Strategic Merger with Oncoinvent ASA
2M ago
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
PremiumCompany Announcements
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
3M ago
BerGenBio ASA Approves Merger Plan with Oncoinvent
PremiumCompany Announcements
BerGenBio ASA Approves Merger Plan with Oncoinvent
3M ago
BerGenBio ASA Announces Virtual Extraordinary General Meeting
PremiumCompany Announcements
BerGenBio ASA Announces Virtual Extraordinary General Meeting
4M ago
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
PremiumCompany Announcements
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
4M ago
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
PremiumCompany AnnouncementsBerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
4M ago
BerGenBio ASA Approves Board Resolutions in Annual Meeting
Premium
Company Announcements
BerGenBio ASA Approves Board Resolutions in Annual Meeting
4M ago
BerGenBio Continues Strategic Review and Ends Bemcentinib Development
Premium
Company Announcements
BerGenBio Continues Strategic Review and Ends Bemcentinib Development
5M ago
BerGenBio ASA Announces Virtual Annual General Meeting
PremiumCompany Announcements
BerGenBio ASA Announces Virtual Annual General Meeting
5M ago
BerGenBio ASA Approves 2024 Financial Statements Amid Strategic Review
PremiumCompany Announcements
BerGenBio ASA Approves 2024 Financial Statements Amid Strategic Review
6M ago
BerGenBio’s Bemcentinib Shows Promise in AML Treatment
PremiumCompany Announcements
BerGenBio’s Bemcentinib Shows Promise in AML Treatment
7M ago
BerGenBio Engages Financial Advisor for Strategic Alternatives Exploration
PremiumCompany Announcements
BerGenBio Engages Financial Advisor for Strategic Alternatives Exploration
8M ago
BerGenBio Reports Q4 2024 Results Amid Strategic Shift
PremiumCompany AnnouncementsBerGenBio Reports Q4 2024 Results Amid Strategic Shift
8M ago
BerGenBio ASA Closes Cancer Study Amid Financial Challenges
Premium
Company Announcements
BerGenBio ASA Closes Cancer Study Amid Financial Challenges
8M ago
BerGenBio ASA Discontinues Lung Cancer Study, Explores Strategic Options
Premium
Company Announcements
BerGenBio ASA Discontinues Lung Cancer Study, Explores Strategic Options
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >